pharma · Shingles
Dynavax International B.V.
Dynavax Technologies drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Dynavax Technologies drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Antiinfectives for systemic use (J07) compound in Dynavax Technologies's portfolio. Mechanism: Biological vaccine - induces immune response.